BP
ELV icon

BNP Paribas’s Elevance Health ELV Stock Holding History

BNP Paribas’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Hold
716
– – 0.01% 220
2025
Q4 		$251K Hold
716
– – 0.01% 232
2025
Q3 		$231K Hold
716
– – 0.01% 214
2025
Q2 		$278K Buy
716
+411
+135% +$165K 0.01% 218
2025
Q1 		$133K Sell
305
-11,163
-97% -$4.48M 0.01% 241
2024
Q4 		$4.23M Sell
11,468
-682
-6% -$285K 0.03% 91
2024
Q3 		$6.32M Sell
12,150
-194
-2% -$104K 0.26% 65
2024
Q2 		$6.69M Sell
12,344
-186
-1% -$98.3K 0.34% 58
2024
Q1 		$6.5M Buy
+12,530
New +$6.23M 0.3% 66

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

BNP Paribas's ELV Position: Q1 2026 in Review

BNP Paribas held its Elevance Health (ELV) position steady in Q1 2026 at 716 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #220.

BNP Paribas first reported a position in ELV in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.69M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • BNP Paribas held 716 shares of Elevance Health worth $210K as of Q1 2026.
  • BNP Paribas left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.01% of BNP Paribas's portfolio in Q1 2026, its #220 holding.
  • BNP Paribas first reported a position in Elevance Health in Q1 2024 and has held it in 9 quarters since.
  • BNP Paribas's Elevance Health position peaked at $6.69M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.